UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Convergence Investment Partners LLC

Convergence Investment Partners LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,521 shares of the healthcare conglomerate’s stock after acquiring an additional 107 shares during the quarter. Convergence Investment Partners LLC’s holdings in UnitedHealth Group were worth $1,327,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the business. Little House Capital LLC raised its position in UnitedHealth Group by 2.4% in the fourth quarter. Little House Capital LLC now owns 8,707 shares of the healthcare conglomerate’s stock worth $4,584,000 after acquiring an additional 204 shares in the last quarter. RiverFront Investment Group LLC increased its position in shares of UnitedHealth Group by 5.9% in the fourth quarter. RiverFront Investment Group LLC now owns 20,985 shares of the healthcare conglomerate’s stock valued at $11,048,000 after buying an additional 1,161 shares in the last quarter. Paradigm Financial Partners LLC increased its position in shares of UnitedHealth Group by 1.0% in the fourth quarter. Paradigm Financial Partners LLC now owns 12,737 shares of the healthcare conglomerate’s stock valued at $6,705,000 after buying an additional 125 shares in the last quarter. Sargent Investment Group LLC increased its position in shares of UnitedHealth Group by 10.5% in the fourth quarter. Sargent Investment Group LLC now owns 2,857 shares of the healthcare conglomerate’s stock valued at $1,504,000 after buying an additional 271 shares in the last quarter. Finally, Stonebrook Private Inc. purchased a new stake in UnitedHealth Group during the 4th quarter worth about $1,488,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on UNH. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Barclays raised their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research note on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $570.05.

Insider Transactions at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

NYSE:UNH traded up $1.49 during mid-day trading on Friday, reaching $495.35. The stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The stock’s 50 day simple moving average is $485.84 and its two-hundred day simple moving average is $514.14. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a market capitalization of $455.76 billion, a price-to-earnings ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the firm posted $6.26 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.